Oestrogen and the cardiovascular system.
Teede
Helena J
HJ
Department of Vascular Sciences and Medicine, Monash University, Dandenong Hospital, Dandenong, Victoria 3175, Australia.
McGrath
Barry P
BP
D001120:Arginine / Q000031:analogs & derivatives* / Q000378:metabolism; D002320:Cardiovascular Physiological Phenomena; D003327:Coronary Disease / Q000378:metabolism / Q000517:prevention & control*; D004730:Endothelium, Vascular / Q000187:drug effects / Q000378:metabolism; D004966:Estrogens, Conjugated (USP) / Q000378:metabolism*; D005260:Female; D006801:Humans; D050356:Lipid Metabolism; D008297:Male; D009569:Nitric Oxide / Q000378:metabolism; D019001:Nitric Oxide Synthase / Q000378:metabolism; D012307:Risk Factors; D020845:Selective Estrogen Receptor Modulators / Q000627:therapeutic use
D004966:Estrogens, Conjugated (USP); D020845:Selective Estrogen Receptor Modulators; D009569:Nitric Oxide; C018524:N,N-dimethylarginine; D001120:Arginine; D019001:Nitric Oxide Synthase